CD14 is a decision-maker between Fas-mediated death and inflammation

Zoie Magri1, David Jetton1, Hayley I Muendlein2

  • 1Graduate Program in Immunology, Tufts Graduate School of Biomedical Sciences, Boston, MA 02111, USA.

Cell Reports
|August 30, 2024
PubMed

Insights

CD14 controls Fas receptor signaling, switching it between pro-death and pro-inflammatory responses in immune cells. This discovery reveals CD14

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Fas receptor signaling was traditionally viewed as a pro-death pathway.
  • Recent studies suggest Fas can also mediate pro-inflammatory responses in disease.
  • The mechanisms governing this switch in Fas signaling remain unclear.

Purpose of the Study:

  • To investigate the role of CD14 in modulating Fas-mediated signaling outcomes.
  • To elucidate how Fas signaling switches between pro-death and pro-inflammatory pathways.

Main Methods:

  • Utilized myeloid cells (macrophages and neutrophils) lacking CD14 (Cd14-/-).
  • Analyzed Fas receptor internalization and downstream signaling pathways.
  • Assessed NF-κB activation and cytokine release following FasL stimulation.

Main Results:

  • CD14 deficiency protected myeloid cells from FasL-induced apoptosis.
  • Cd14-/- myeloid cells exhibited increased NF-κB activation and cytokine production.
  • CD14 was essential for Fas-mediated signaling through TRIF, including pro-death complex formation.

Conclusions:

  • CD14 acts as a critical regulator of Fas receptor internalization.
  • CD14 availability determines whether Fas signaling results in cell death or inflammation.
  • Targeting CD14 could modulate Fas-mediated immune responses in pathological conditions.